YHR137C-A Antibody

What is YHR137C-A and what is its significance in Saccharomyces cerevisiae research?

YHR137C-A is a protein encoded by the YHR137C-A gene in Saccharomyces cerevisiae (baker's yeast), with UniProt accession number Q8TGN6 . While the specific function of this protein remains under investigation, it has been included in functional genomics and bioinformatics approaches studying gene expression patterns during cellular responses .

The protein is of particular interest in studies examining differential gene expression during cellular stress responses and programmed cell death pathways in yeast. As referenced in comprehensive transcriptomic analyses, YHR137C-A may be among the genes that show altered expression patterns during these cellular processes, potentially serving as a marker for monitoring changes in cellular status .

What are the key specifications of commercially available YHR137C-A antibodies?

The YHR137C-A antibody is typically available as a polyclonal antibody raised in rabbits, using recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YHR137C-A protein as the immunogen . These antibodies are commonly supplied in liquid form, in a storage buffer containing preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4) .

The antibody is generally purified using antigen affinity methods to enhance specificity and reduce background. For research applications, it has been validated for use in techniques including ELISA and Western blotting . As a research-grade reagent, the antibody is intended solely for research purposes and not for diagnostic or therapeutic applications .

How does YHR137C-A differ from other yeast proteins, and what challenges might this present for antibody specificity?

YHR137C-A exists within the complex yeast proteome, which includes numerous paralogs resulting from whole genome duplication (WGD) events in yeast evolutionary history . The presence of paralogous proteins presents particular challenges for antibody specificity and cross-reactivity.

Functional genomics studies have identified paralog substitution patterns in yeast under different cellular conditions, particularly during programmed cell death . These substitution patterns involve differential expression of paralogous pairs, which can complicate antibody-based detection if epitopes are conserved between paralogs. Researchers should be aware that under certain experimental conditions, paralog substitution might occur, potentially affecting the interpretation of results when using the YHR137C-A antibody .

What storage and handling protocols are recommended for maintaining YHR137C-A antibody activity?

To maintain optimal activity of YHR137C-A antibody, proper storage and handling are crucial:

• Upon receipt, store the antibody at -20°C or -80°C for long-term preservation

• Avoid repeated freeze-thaw cycles as they can compromise antibody integrity and performance

• Consider preparing small working aliquots to minimize freeze-thaw events

• When handling, maintain cold chain practices, keeping the antibody on ice when in use

• For dilution, use buffers similar to the storage buffer (PBS-based with stabilizers)

Proper adherence to these storage conditions will help maintain antibody activity and ensure consistent experimental results over time. If decreased activity is observed, this may indicate degradation due to improper storage or handling.

What controls should be incorporated when designing experiments using YHR137C-A antibody?

A robust experimental design using YHR137C-A antibody should include these essential controls:

• Positive control: Samples known to express YHR137C-A protein, such as wild-type S. cerevisiae S288c strain

• Negative control: Samples where YHR137C-A is absent or knocked out to confirm antibody specificity

• Loading control: Detection of a constitutively expressed housekeeping protein to normalize expression levels

• Secondary antibody-only control: Omitting primary antibody to detect non-specific binding of secondary antibody

• Blocking peptide control: Pre-incubation of antibody with immunizing peptide to validate specificity

This comprehensive control strategy mirrors approaches used with other research antibodies, such as those described for CD20 antibody validation, where multiple controls are employed to ensure reliable results .

What are the recommended protocols for Western blot application of YHR137C-A antibody?

For optimal Western blot results with YHR137C-A antibody, consider the following methodology:

• Sample preparation:

  • Extract total protein from yeast using glass bead lysis or enzymatic cell wall digestion

  • Include protease inhibitors to prevent degradation

  • Denature samples in standard loading buffer (with DTT or β-mercaptoethanol)

• Gel electrophoresis and transfer:

  • Use 10-15% polyacrylamide gels depending on the expected molecular weight

  • Transfer to PVDF or nitrocellulose membranes using standard protocols

• Antibody incubation:

  • Block membranes with 3-5% BSA or non-fat dry milk in TBST

  • Dilute YHR137C-A antibody to optimal concentration (typically 1:500 to 1:2000)

  • Incubate overnight at 4°C with gentle agitation

  • Wash thoroughly with TBST before adding appropriate secondary antibody

• Detection:

  • Use enhanced chemiluminescence or fluorescence-based detection systems

  • Optimize exposure times to prevent signal saturation

This approach follows standard Western blot methodologies used for other antibodies in yeast research, adapting dilutions and conditions specifically for YHR137C-A detection .

How can YHR137C-A antibody be utilized in immunofluorescence applications with yeast cells?

For successful immunofluorescence with YHR137C-A antibody in yeast cells:

• Cell fixation and permeabilization:

  • Fix yeast cells with 3.7% formaldehyde for 30-60 minutes

  • Treat with zymolyase to create spheroplasts (removing cell wall)

  • Permeabilize with 0.1% Triton X-100 to allow antibody access

• Antibody incubation:

  • Block with 1-3% BSA in PBS for 30-60 minutes

  • Apply YHR137C-A antibody at optimized dilution (typically 1:50 to 1:200)

  • Incubate overnight at 4°C in a humidified chamber

  • Wash extensively with PBS before applying fluorophore-conjugated secondary antibody

• Visualization:

  • Use appropriate filters for secondary antibody fluorophore

  • Include DAPI counterstain for nuclear visualization

  • Consider confocal microscopy for improved resolution

Similar approaches have proven successful with other yeast proteins and can be adapted for YHR137C-A localization studies, comparable to the methodology used for visualizing membrane proteins like CD20 .

How can YHR137C-A antibody be used to study gene expression changes during programmed cell death in yeast?

YHR137C-A antibody can be employed to investigate protein-level changes during programmed cell death in yeast through several approaches:

• Time-course analysis:

  • Trigger programmed cell death using established inducers

  • Harvest cells at defined time points (0, 2, 4, 8, 12, 24 hours)

  • Perform Western blot analysis to track YHR137C-A protein levels

  • Correlate protein expression with other markers of programmed cell death

• Comparative analysis:

  • Compare YHR137C-A expression between cells undergoing programmed cell death versus other stress responses

  • This approach can identify expression signatures specific to cell death rather than general stress

• Co-expression studies:

  • Examine YHR137C-A expression alongside known cell death markers

  • Investigate whether YHR137C-A follows similar expression patterns to genes involved in ribosome biogenesis or protein translation, which are known to undergo significant changes during programmed cell death

Research suggests that programmed cell death in yeast involves specific changes in gene expression, including alterations in ribosomal protein paralog substitution and protein translation machinery . Using YHR137C-A antibody in these contexts can provide insights into whether this protein participates in these cellular processes.

What is the relationship between YHR137C-A and ribosomal stress response pathways?

While direct evidence linking YHR137C-A to ribosomal stress response is not explicitly described in the available data, several experimental approaches can be used to investigate potential connections:

• Comparative expression analysis:

  • Induce ribosomal stress using translation inhibitors (cycloheximide, anisomycin)

  • Compare YHR137C-A expression levels before and after treatment

  • Examine co-expression with known ribosomal stress regulators like IFH1 and CRF1

• Genetic interaction studies:

  • Create strains with YHR137C-A deletion in combination with mutations in ribosomal stress pathway genes

  • Assess synthetic phenotypes suggesting functional relationships

  • Monitor growth rates and viability under various stress conditions

• Protein localization during stress:

  • Use immunofluorescence to track YHR137C-A localization during ribosomal stress

  • Determine if YHR137C-A co-localizes with ribosomal components or stress granules

This approach is particularly relevant given that yeast undergoes significant reprogramming of protein translation machinery during stress and programmed cell death, including substitution of paralogs of ribosomal proteins in the assembly of ribosomal subunits .

How can YHR137C-A antibody be integrated into multi-omics approaches to understand yeast cellular responses?

Integration of YHR137C-A antibody-based detection into multi-omics approaches can provide comprehensive insights into yeast cellular responses:

• Correlation with transcriptomics data:

  • Compare protein levels detected by YHR137C-A antibody with mRNA expression data

  • Identify potential post-transcriptional regulation mechanisms

  • Establish temporal relationships between transcript and protein expression changes

• Integration with proteomics:

  • Use YHR137C-A antibody for immunoprecipitation followed by mass spectrometry

  • Identify protein interaction partners under different conditions

  • Compare with global proteomics data to place YHR137C-A in relevant protein networks

• Functional genomics correlation:

  • Combine antibody-based detection with phenotypic data from gene deletion studies

  • Correlate YHR137C-A expression levels with specific cellular outcomes

  • Integrate with data from paralog expression studies to understand gene redundancy effects

This multi-omics approach mirrors strategies employed in comprehensive functional genomics studies that have successfully identified early molecular markers of programmed cell death and stress response in yeast .

What techniques can be used to study post-translational modifications of YHR137C-A?

To investigate post-translational modifications (PTMs) of YHR137C-A, researchers can employ the following methodologies:

• Phosphorylation analysis:

  • Immunoprecipitate YHR137C-A using the specific antibody

  • Perform Western blot with phospho-specific antibodies

  • Alternatively, use Phos-tag gels to detect mobility shifts caused by phosphorylation

  • Compare phosphorylation states under different cellular conditions

• Mass spectrometry approaches:

  • Immunoprecipitate YHR137C-A followed by tryptic digestion

  • Perform LC-MS/MS analysis to identify specific modification sites

  • Use quantitative proteomics to compare modification levels between conditions

• 2D gel electrophoresis:

  • Separate proteins by isoelectric point and molecular weight

  • Detect YHR137C-A isoforms using the specific antibody

  • Identify shifts indicating post-translational modifications

This approach is relevant given observations that allelic differences in yeast proteins can lead to differences in phosphorylation states, as observed with the RPI1 transcription factor , and similar mechanisms might affect YHR137C-A function.

How can researchers validate the specificity of YHR137C-A antibody?

To validate YHR137C-A antibody specificity, implement these complementary approaches:

• Genetic validation:

  • Test the antibody on samples from YHR137C-A deletion strains

  • Absence of signal in knockout strains confirms specificity

  • Compare with wild-type strains to verify correct target detection

• Epitope competition assay:

  • Pre-incubate the antibody with excess immunizing peptide/protein

  • Apply to Western blot or other detection methods

  • Signal elimination indicates specific binding to the target epitope

• Cross-reactivity assessment:

  • Test the antibody on related yeast species or distant strains

  • Evaluate signal in strains with known sequence variations in YHR137C-A

  • Assess potential cross-reactivity with paralogous proteins

• Expression correlation:

  • Compare protein detection levels with known mRNA expression data

  • Verify that protein levels change as expected under conditions known to affect gene expression

These validation methods are essential to ensure reliable interpretation of results, particularly when studying proteins involved in complex cellular processes .

What factors can affect the reproducibility of YHR137C-A antibody experiments?

Several factors can impact experimental reproducibility when using YHR137C-A antibody:

• Antibody stability and handling:

  • Degradation due to improper storage or repeated freeze-thaw cycles

  • Batch-to-batch variations in antibody production

  • Inconsistent dilution or preparation methods

• Sample preparation variables:

  • Differences in yeast growth conditions affecting protein expression

  • Variations in cell lysis efficiency and protein extraction

  • Protein degradation during sample processing

  • Inconsistent protein quantification before loading

• Experimental conditions:

  • Variations in blocking reagents or incubation times

  • Inconsistent transfer efficiency in Western blots

  • Differences in detection reagents or imaging parameters

• Biological variables:

  • Cell cycle-dependent expression of YHR137C-A

  • Strain-specific differences in expression or protein characteristics

  • Metabolic state of yeast cultures affecting protein levels

Controlling these variables requires careful standardization of protocols and inclusion of appropriate controls in each experiment .

What are common pitfalls when interpreting YHR137C-A expression data across different experimental conditions?

When interpreting YHR137C-A expression data, researchers should be aware of these potential pitfalls:

• Background signal misinterpretation:

  • Non-specific antibody binding may be misinterpreted as low-level expression

  • Cross-reactivity with similar proteins can confound results

  • Secondary antibody binding to endogenous immunoglobulins in samples

• Normalization challenges:

  • Inappropriate selection of housekeeping genes/proteins for normalization

  • Housekeeping gene expression may vary under certain experimental conditions

  • Inconsistent loading or transfer can create artificial differences

• Contextual interpretation errors:

  • Failure to consider paralog substitution effects in gene families

  • Neglecting potential post-translational modifications affecting detection

  • Not accounting for strain-specific allelic differences affecting protein function

• Temporal dynamics oversight:

  • Missing transient expression changes by examining only single time points

  • Failing to capture the relationship between mRNA and protein expression kinetics

  • Not considering protein degradation rates under different conditions

Awareness of these pitfalls enables more accurate interpretation of results and development of appropriate controls to address potential confounding factors .

How should researchers approach contradictory results between antibody-based detection and gene expression data for YHR137C-A?

When faced with discrepancies between protein detection and gene expression data:

• Verify temporal relationship:

  • Protein expression often lags behind mRNA expression

  • Implement time-course experiments to capture expression dynamics

  • Consider protein half-life and stability factors

• Investigate post-transcriptional regulation:

  • Assess mRNA stability and translation efficiency

  • Examine potential miRNA regulation of YHR137C-A

  • Consider conditional translational regulation during stress

• Evaluate protein degradation mechanisms:

  • Test if protein degradation rates change under experimental conditions

  • Examine ubiquitination or other degradation signals

  • Use proteasome inhibitors to determine if discrepancies resolve

• Technical validation:

  • Use alternative detection methods (mass spectrometry, different antibodies)

  • Implement RNA-protein correlation analyses with spike-in controls

  • Consider epitope masking due to protein interactions or modifications

These approaches recognize that mRNA and protein levels often do not directly correlate due to the complex regulatory mechanisms governing gene expression and protein turnover .

How does working with YHR137C-A antibodies compare to using antibodies against human proteins in research?

Working with YHR137C-A antibodies presents distinct considerations compared to human protein antibodies:

This comparison highlights the need for tailored approaches when working with yeast antibodies compared to human protein antibodies, particularly regarding validation methods and application contexts .

What insights from YHR137C-A research in yeast might be applicable to human cellular processes?

Research on YHR137C-A in yeast may provide translatable insights to human biology:

• Conservation of fundamental processes:

  • Many basic cellular mechanisms are conserved from yeast to humans

  • Insights into YHR137C-A's role in processes like programmed cell death may illuminate conserved pathways

  • Yeast serves as a model system for understanding fundamental eukaryotic processes

• Translational research pathways:

  • If YHR137C-A is involved in ribosomal stress response, findings may inform understanding of human ribosomal diseases

  • Identification of YHR137C-A as a marker for cellular states could lead to development of similar markers in human cells

  • Methods developed for studying YHR137C-A may be adaptable to human protein studies

• Drug discovery implications:

  • Understanding YHR137C-A's role in cellular processes could inform development of compounds that modulate similar pathways in humans

  • Similar to approaches described for identifying natural compounds that modulate programmed cell death in humans

This translational perspective emphasizes the value of yeast research in providing foundational knowledge applicable to human health and disease .

How can YHR137C-A antibody be integrated into biosensor development for monitoring yeast cellular states?

The development of biosensors incorporating YHR137C-A antibody could enable real-time monitoring of yeast cellular states:

• Antibody-based biosensor designs:

  • Immobilize YHR137C-A antibody on sensor surfaces (gold nanoparticles, quantum dots)

  • Couple with electrochemical or optical detection systems

  • Calibrate sensor response to protein concentration

• Applications in bioprocess monitoring:

  • If YHR137C-A serves as a marker for specific cellular states, biosensors could monitor:

    • Metabolic status in bioreactors

    • Stress response in industrial fermentation

    • Early detection of programmed cell death in cultures

• Integration with existing monitoring systems:

  • Combine YHR137C-A detection with other cellular markers

  • Develop multiplexed detection systems for comprehensive monitoring

  • Implement automated sampling and detection for continuous monitoring

This approach aligns with research suggesting the value of molecular markers for monitoring cell growth in bioreactors and implementing biosensors to track cellular responses .